Back to search results

Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID

Abroad (travel likely)RecruitingPHASE2

Conditions

Long COVID

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cardio Health, Brampton, Ontario, Canada

    Contact: Study coordinator (Amarjot Bhatia) · amarjot@cardio-health.ca · 226-797-5974
    Contact: Principal Investigator (Fairoze Poonah, MD)

  • Cardio Health, London, Ontario, Canada

    Contact: Study coordinator (Naheed Rizvi, MD) · naheed@cardio-health.ca · 226-783-4649
    Contact: Principal Investigator (Marius Naghiu, MD)

  • Cardio Health, Mississauga, Ontario, Canada

    Contact: Study coordinator (Jamie Kwon) · jamie@cardio-health.ca · 226-797-5974
    Contact: Principal Investigator (Sadaf Sarwar, MD)

  • Cardio Health, North York, Ontario, Canada

    Contact: Study coordinator (Mala Singh) · mala@cardio-health.ca · 905-882-4848
    Contact: Principal Investigator (Emma Benedict, MD)
Study leads

  • Sam Bock, BA Environmental Science

    Study Director

    ParagonClinicals Inc CEO / CSO

View source on ClinicalTrials.gov(opens in a new tab)